GBI Research, has released its latest pharma report, "Acute Myeloid Leukemia Therapeutics Market to 2020 - Treatment and prognosis in AML is strongly influenced by a patient's age, and their cytogenetic profile. In the majority of cases these two prognostic influences are linked, with a higher frequency of unfavorable cytogenetic abnormalities observed in the elderly.
http://reports.pr-inside.com/new-market-research-report-acute-myeloid-r4180699.htm
http://reports.pr-inside.com/new-market-research-report-acute-myeloid-r4180699.htm
No comments:
Post a Comment